Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions

  1. Herzog, T.J.
  2. Wahab, S.A.
  3. Mirza, M.R.
  4. Pothuri, B.
  5. Vergote, I.
  6. Graybill, W.S.
  7. Malinowska, I.A.
  8. York, W.
  9. Hurteau, J.A.
  10. Gupta, D.
  11. González-Martin, A.
  12. Monk, B.J.
Revue:
International Journal of Gynecological Cancer

ISSN: 1525-1438 1048-891X

Année de publication: 2023

Volumen: 33

Número: 11

Pages: 1733-1742

Type: Article

DOI: 10.1136/IJGC-2023-004605 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable